TL;DR — Bromelain is a mixture of proteolytic enzymes from pineapple stem and fruit. Real RCT evidence for post-surgical / post-injury edema and pain reduction (Kerkhoffs 2004 PMID 15150435 — ankle sprain), acute sinusitis symptom relief (Guo 2018 PMID 30319719 meta), and adjunct osteoarthritis pain. Standard dose 500–2,000 mg/day (2,400 GDU/g) between meals; with meals reduces protein digestion. Well tolerated. Real anticoagulant potentiation to know about.
What bromelain does (and why it matters)
Bromelain refers to a family of thiol proteases in Ananas comosus (pineapple). Stem bromelain (higher activity) is the main commercial source. It hydrolyzes peptideA short chain of amino acids — smaller than a full protein — that usually acts on a specific cell-surface receptor rather than a broad metabolic pathway. Full glossary → bonds broadly and, taken between meals, appears to enter the circulation intact enough to have systemic effects.
Bromelain's clinical value is post-inflammatory / edema reduction — well-documented in sports medicine, post-surgical dental, and sinusitis contexts. The mechanism is a combination of: - Direct fibrinolysis — degrades fibrin exudate in acute inflammation - Bradykinin degradation — reduces the inflammatory kinin cascade - Anti-adhesive — modulates leukocyte-endothelial trafficking
Primary hallmarks targeted: Chronic inflammation (edema, exudate) · Altered intercellular communication (kinin, fibrin)
Kerkhoffs et al. (2004, PMID 15150435) — 90 ankle sprain patients — bromelain protocol accelerated pain and swelling resolution vs standard care. Guo et al. (2018, PMID 30319719) meta-analysis of acute sinusitis RCTs — bromelain 500 mg/day reduced symptom duration and severity. Brien et al. (2004, PMID 15140254) meta of OA RCTs — bromelain modestly reduced knee OA pain. Braun et al. (2005) — reduced knee OA pain and joint stiffness at 240 mg/day for 12 weeks.
Mechanism
| Pathway | Mechanism | Hallmark link |
|---|---|---|
| Fibrinolysis | Direct enzymatic degradation of fibrin | Communication |
| Bradykinin degradation | Reduces inflammatory kinin pool | Inflammation |
| Anti-edema | Improves lymphatic drainage of exudate | Inflammation |
| Prostaglandin modulation | Small effect via arachidonic acid pathway | Inflammation |
| Immune modulation | ↓ CD44 shedding; alters leukocyte trafficking | Communication |
Unlike serrapeptase, bromelain has better human PK data — enteric-coated and enteric-resistant formulations reliably deliver systemic activity. Absorption is estimated at 40% for intact enzyme.
When bromelain is worth using
Bromelain earns a place when one or more apply:
- Acute soft-tissue injury (ankle sprain, contusion, post-surgical edema)
- Acute or chronic sinusitis (adjunct to standard care)
- Osteoarthritis pain (modest, sustained use)
- Building an anti-inflammatory stack for training recovery
Skip or defer if on anticoagulants (real interaction), have active peptic ulcer, or are pregnant.
Evidence summary
| Study | Design | N | Duration | Key outcomes | Tier |
|---|---|---|---|---|---|
| Kerkhoffs 2004 (PMID 15150435) | RCT (ankle sprain) | 90 | 14 d | Faster pain/swelling resolution | B |
| Guo 2018 meta (PMID 30319719) | Meta (sinusitis) | Multiple | Various | ↓ Symptom duration + severity | B |
| Braun 2005 (RCT) | RCT (knee OA) | 90 | 12 wk | ↓ Pain + stiffness at 240 mg | B |
| Brien 2004 meta (PMID 15140254) | Meta (OA) | 4 RCTs | 4–12 wk | Modest OA pain reduction | C |
← Swipe for more columns →
Consensus: Tier B for acute inflammatory / edema conditions (sports medicine, post-surgical, sinusitis). Modest for OA pain. Well-tolerated.
Where bromelain disappoints
- Not for chronic autoimmune inflammation. Bromelain reduces acute exudate but doesn't address chronic RA or lupus-driven inflammation. - Product potency (GDU/g) varies widely. RCT dosing uses standardized activity (typically 2,400 GDU/g); cheap products at 1,200 GDU/g need double the mass. - Taken with meals it just digests protein — the therapeutic use requires between-meal dosing.
Dosing protocol
| Parameter | Recommendation | Notes |
|---|---|---|
| Acute injury / post-op | 500–1,000 mg TID (2,400 GDU/g) between meals | 3–7 days |
| Sinusitis | 500 mg TID × 5–7 days | Combine with saline irrigation |
| OA (chronic) | 240–500 mg BID (up to 90 days) | Combine with joint stack |
| Timing | Between meals (empty stomach) | With food = digestive enzyme use |
| Digestive use (different indication) | 200 mg with meals | For protein digestion, not systemic effect |
Monitoring
| Biomarker | Target | Frequency | Action if off-target |
|---|---|---|---|
| Pain / swelling (acute use) | Resolving faster than standard | Daily first week | Standard care remains primary |
| Bleeding signs | None | Ongoing | Discontinue immediately if noted |
| INR (if on warfarin) | Stable | Weekly first 2 weeks | Dose-adjust warfarin |
← Swipe for more columns →
Safety, red flags, and contraindications
- Well tolerated; GI upset ~5%, allergic reactions rare.
- Pineapple allergy — cross-reactivity possible.
Do not self-start without clearance
- On warfarin, DOACs, antiplatelets — real, clinically-relevant additive bleeding effect.
- Active peptic ulcer or gastritis — proteolytic activity may worsen.
- Scheduled surgery — discontinue 2 weeks before.
- Pineapple / latex allergy — cross-reactivity risk.
- Pregnancy — insufficient safety data.
Synergies and antagonists
Pairs well with:
| Partner | Rationale | Guide |
|---|---|---|
| Curcumin | Complementary anti-inflammatory mechanisms | Anti-inflammatory |
| Quercetin | Synergistic in acute inflammation; often combined for post-viral | Anti-inflammatory |
| Serrapeptase | Similar proteolytic profile; combined in some post-surgical protocols | Recovery stack |
| Fish oil | Additive anti-inflammatory for OA / joint | Joint stack |
Works against / redundant with:
| Antagonist | Conflict | What to do |
|---|---|---|
| Warfarin / DOACs | Additive bleeding | Do not combine without MD monitoring |
| Aspirin / NSAIDs (chronic) | Additive antiplatelet + GI risk | Cap combined use |
| Antibiotics (some peptide) | Protease degradation | Separate by 2+ hours |
References
Links open PubMed. TNiC does not sell supplements; citations support education, not medical advice.